Enter your login e-mail to the account
Search
Search parameters
Search results
- The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(11/2009, Review articles ) - How early diagnose urological malignancy in the office of a general practitioner
doc. MUDr. Jozef Marenčák, PhD.
(5/2014, Review articles )
- Stem cell transplantation in pediatric patients with bone marrow failure
MUDr. Peter Švec, PhD., MUDr. Sabina Šufliarska, PhD., MUDr. Júlia Horáková, PhD., MUDr. Ivana Boďová, PhD., MUDr. Jana Košťálová, MUDr. Alica Chocholová, PhD., MUDr. Lucia Géczová
(1/2016, Original articles & Case reports )
- Metachronous metastasis of renal cell carcinoma to the urinary bladder
MUDr. Jaroslav Andriychuk, MUDr. Radomír Zachoval, Ph.D., MUDr. Martin Sutorý, CSc., MUDr. Petr Kumstát, MUDr. Hana Dokulilová
(3/2019, Communication from practice ) - Imunoterapie u nádorů ledvin
MUDr. Andrea Ondrušková, doc. MUDr. Hana Študentová, Ph.D.
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Sarcomatoid differentiation as a histopathological prognostic parameter in renal cell carcinoma
MUDr. Vladimír Bartoš, MUDr. Dušan Pokorný, MUDr. Oľga Zacharová, MUDr. Roman Mráz, MUDr. Juraj Mikuláš, CSc., MUDr. Peter Laurinc
(4/2012, Original articles & case reports ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Health technology assessment and value for money in drug policy
PharmDr. Martin Višňanský, MBA, PhD., MSc., Mgr. Radoslav Suchovič
(2/2017, Main topic ) - Importance of immunohistochemistry and application of TTF-1 and napsin A in differential diagnosis of primary pulmonary adenocarcinomas and pulmonary metastases of extrapulmonary origins
MUDr. Adela Mikuľaková, MUDr. Zuzana Hríbiková
(2/2017, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - New trends in the treatment of non-small cell renal cell carcinoma
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(4/2022, Main topic ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(6/2009, Information & comments ) - Selected epidemiological data of kidney and bladder cancer in the SR and CR
prof. MUDr. Dalibor Ondruš, DrSc., RNDr. Martina Ondrušová, PhD.
(5/2010, Review articles ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - Surgical treatment of renal cell carcinomas
prof. MUDr. Ján Breza, DrSc.
(5/2010, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - XVII. košické chemoterapeutické dni
MUDr. Dávid Martinický
(1/2014, Events ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Role of pathologist in the diagnosis of cancer of unknown primary origin
doc. MUDr. Karol Kajo, PhD.
(4/2013, Main topic ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - XLIII. bratislavských onkologických dní – správa z podujatia
MUDr. Oľga Szegheőová
(4/2006, Events ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Current trends in surgery of Wilms tumor
MUDr. Terézia Stančoková, MUDr. Pavel Bician, MUDr. Vladimír Baláž, PhD., MUDr. Ján Novotný, MUDr. Jozef Babeľa, MUDr. Július Janek, PhD., MUDr. Roman Koreň, PhD.
(1/2016, Main topic ) - SPRÁVA Z XLV. ROČNÍKA BRATISLAVSKÝCH ONKOLOGICKÝCH DNÍ, 1. – 3. OKTÓBER 2008
MUDr. Ľubica Švancárová
(6/2008, Events ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(5/2009, Review articles ) - Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )
- Tumory neznámej diferenciácie a nediferencované sarkómy mäkkých tkanív v praxi dermatopatológa
prof. MUDr. Katarína Adamicová, PhD., doc. MUDr. Želmíra Fetisovová, PhD.
(2/2018, Interdisciplinary consilium )